Krystal Biotech (KRYS) Research & Development: 2021-2025
Historic Research & Development for Krystal Biotech (KRYS) over the last 5 years, with Sep 2025 value amounting to $14.6 million.
- Krystal Biotech's Research & Development rose 7.94% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.8 million, marking a year-over-year increase of 10.40%. This contributed to the annual value of $53.6 million for FY2024, which is 15.38% up from last year.
- Krystal Biotech's Research & Development amounted to $14.6 million in Q3 2025, which was up 1.21% from $14.4 million recorded in Q2 2025.
- In the past 5 years, Krystal Biotech's Research & Development registered a high of $15.6 million during Q2 2024, and its lowest value of $6.1 million during Q3 2021.
- For the 3-year period, Krystal Biotech's Research & Development averaged around $13.0 million, with its median value being $13.5 million (2024).
- In the last 5 years, Krystal Biotech's Research & Development surged by 89.41% in 2022 and then fell by 10.83% in 2024.
- Krystal Biotech's Research & Development (Quarterly) stood at $9.0 million in 2021, then grew by 19.23% to $10.7 million in 2022, then grew by 5.86% to $11.4 million in 2023, then rose by 18.92% to $13.5 million in 2024, then increased by 7.94% to $14.6 million in 2025.
- Its Research & Development stands at $14.6 million for Q3 2025, versus $14.4 million for Q2 2025 and $14.3 million for Q1 2025.